Abstract: The injection-locked ring oscillator is being widely used in high-speed wireline transceivers to generate multi-phase clocks. The fundamental limit lies in the tradeoff between the number of ...

Biogen is looking to the future of its spinal muscular atrophy (SMA) business, taking an Ionis-partnered candidate that could offer dosing just once a year into pivotal trials on the strength of ...

Roche has posted a mixed set of data from two clinical trials of its anti-IL-33/ST2 antibody astegolimab in chronic obstructive pulmonary disease (COPD), casting a shadow over the programme. On the ...

Alan Kohler has been a financial journalist for 46 years. He began as a cadet on The Australian covering the Poseidon boom and bust; has been a columnist for Chanticleer in the Australian Financial ...

Vir Biotechnology (VIR) “announced that the first patient has been dosed in Part 3 of the Company’s Phase 1 clinical trial evaluating VIR-5500 in combination with androgen receptor pathway inhibitors.

The 36 teams have discovered their fate for the UEFA Europa League league phase.

MoonLake Immunotherapeutics (MLTX) shares plunged after the company reported results from its Phase 3 trials for sonelokimab in hidradenitis suppurativa. The VELA-2 study missed its main goal, ...

Mumbai Metro Phase 3 Inauguration | Inside Mumbai Metro Line 3 Final Phase, PM Modi To Inaugurate Mumbai Metro Line 3 (Aqua Line) is scheduled to fully open on Oct. 8. It is the city’s first ...

NEW DELHI: A top executive of homegrown telecom gear maker HFCL said it has won deals in 40-45% gram panchayats (GPs) under the BharatNet Phase 3 programme, and has started supplying its network ...

Mumbai (Maharashtra) [India], October 8 (ANI): Prime Minister Narendra Modi on Wednesday lauded the inauguration of Phase 2B of the Mumbai Metro Line-3, describing it as a "significant enhancement" to ...

ANAVEX3-71-SZ-001 achieved its primary endpoint demonstrating safety and tolerability in adults with schizophrenia Encouraging trends observed in biomarkers support continued development NEW YORK, Oct ...